AKT1 and obesity disorder: In a mouse model of hepatocellular carcinoma initiated by diethylnitrosamine administration and promoted by dietary or genetic obesity, PI3Kγ ablation reduced tumor growth, insulinemia, and steatosis [34], suggesting a preponderant role for PI3K/Akt signaling in obesity-induced cancer.